PubMed HealthSearch

PubMed · 9547434

The analysis of small-sample multivariate data.

Abstract

Clinical pharmacology studies typically consist of few subjects per treatment group, but with many, possibly highly correlated, measurements taken per subject. Permutational methods for testing equality of the multivariate treatment means when the number of variables exceeds the number of independent subjects have been developed, but are highly computationally intensive. In this paper, a parametric test was derived, using Edgeworth expansions, for the case of two groups, and compared with competing test statistics proposed by Mercante and Johnson (7), Dempster (5), Chung and Fraser (3), Mantel and Valand (6). The proposed test compares favorably with the others in terms of type I error rate, as well as power, and has the advantages of not requiring computationally intensive resources and being easily extendable to more than two groups.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H Saranadasa, S Altan. 1998. The analysis of small-sample multivariate data.. https://doi.org/10.1080/10543409808835229

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

New antithrombotic agents.

The development of new antithrombotic agents has been stimulated by clinical needs and by advances in biotechnology that have made it possible to produce drugs that target specific steps in thrombogenesis. Heparin has pharmacokinetic and biophysical limitations that are overcome by new anticoagulants. Of these, low-molecular-weight heparin and direct inhibitors of thrombin have been evaluated clinically. Coumarins require careful laboratory monitoring because of concerns about safety. Orally active direct inhibitors of thrombin and factor Xa may replace coumarins. Aspirin is of limited efficacy because it inhibits only one pathway of platelet activation. Inhibitors of adenosine diphosphate receptor and glycoprotein IIb/IIIa antagonists are more effective than aspirin and are used in the clinic.

Clinical Trials as Topic